Arena Pharmaceuticals, Inc.

ARNANASDAQHealthcare

$99.99

+$0.00(+0.00%)

Market Cap$0

P/E Ratio—

52W High$100

52W Low$99.97

Avg Volume1.5M

Open$99.97

Beta0.55

Earnings Financials Revenue

Arena Pharmaceuticals, Inc. (ARNA) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

ARNA · earnings · updated Jun 9, 2026

Latest Earnings

Q1 FY2022Report Date: Feb 23, 2022

EPS Actual

-$2.39

Est. -$2.26 · -5.8%

Revenue

$0.00B

Est. $0.00B · -93.7%

Fiscal Period

Q1 FY2022

FY ends December

Report Date

Feb 23, 2022

After Market Close

▼ Miss EPS▼ Miss Revenue

ARNA reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$93.32

Rev. $1001.5B

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$93.32

Rev. Est.$1001.5B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2022	May 4, 2022	-$2.32	—	—	—	$0.00B	—
▼ Q1 FY2022	Feb 23, 2022	-$2.26	-$2.39	-5.8%	$0.00B	$0.00B	-93.7%
▼ Q4 FY2021	Nov 4, 2021	-$2.53	-$3.21	-26.9%	—	$0.00B	—
▼ Q3 FY2021	Aug 5, 2021	-$2.20	-$2.40	-9.1%	—	—	—
▲ Q2 FY2021	May 5, 2021	-$2.16	-$1.98	+8.3%	—	$0.00B	—
▼ Q1 FY2021	Feb 23, 2021	-$1.85	-$2.10	-13.5%	$0.00B	$0.00B	-92.8%
▲ Q4 FY2020	Nov 9, 2020	-$1.87	-$1.69	+9.6%	$0.00B	$0.00B	-8.8%
▲ Q3 FY2020	Aug 5, 2020	-$2.03	-$1.61	+20.7%	—	—	—

Q2 FY2022

May 4, 2022

EPS Actual

—

EPS Est.

-$2.32

EPS Surpr.

—

Revenue

—

Q1 FY2022

Feb 23, 2022Miss

EPS Actual

-$2.39

EPS Est.

-$2.26

EPS Surpr.

-5.8%

Revenue

$0.00B

Q4 FY2021

Nov 4, 2021Miss

EPS Actual

-$3.21

EPS Est.

-$2.53

EPS Surpr.

-26.9%

Revenue

—

Q3 FY2021

Aug 5, 2021Miss

EPS Actual

-$2.40

EPS Est.

-$2.20

EPS Surpr.

-9.1%

Revenue

—

Q2 FY2021

May 5, 2021Beat

EPS Actual

-$1.98

EPS Est.

-$2.16

EPS Surpr.

+8.3%

Revenue

—

Q1 FY2021

Feb 23, 2021Miss

EPS Actual

-$2.10

EPS Est.

-$1.85

EPS Surpr.

-13.5%

Revenue

$0.00B

Q4 FY2020

Nov 9, 2020Beat

EPS Actual

-$1.69

EPS Est.

-$1.87

EPS Surpr.

+9.6%

Revenue

$0.00B

Q3 FY2020

Aug 5, 2020Beat

EPS Actual

-$1.61

EPS Est.

-$2.03

EPS Surpr.

+20.7%

Revenue

—

No analyst estimates available for ARNA.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▼ Q1 FY2022	Feb 23, 2022	-5.8%	$93.76	$93.99	+0.25%
▼ Q4 FY2021	Nov 4, 2021	-26.9%	$63.44	$63.00	-0.69%
▼ Q3 FY2021	Aug 5, 2021	-9.1%	$59.37	$62.10	+4.60%
▲ Q2 FY2021	May 5, 2021	+8.3%	$64.00	$64.30	+0.47%
▼ Q1 FY2021	Feb 23, 2021	-13.5%	$78.65	$76.56	-2.66%
▲ Q4 FY2020	Nov 9, 2020	+9.6%	$86.64	$87.42	+0.90%
▲ Q3 FY2020	Aug 5, 2020	+20.7%	$63.61	$64.43	+1.29%
▲ Q2 FY2020	May 7, 2020	+12.3%	$49.98	$49.85	-0.26%

Q1 FY2022+0.25%

Report Date

Feb 23, 2022

EPS Beat/Miss

-5.8%

Price Before

$93.76

Price After

$93.99

Q4 FY2021-0.69%

Report Date

Nov 4, 2021

EPS Beat/Miss

-26.9%

Price Before

$63.44

Price After

$63.00

Q3 FY2021+4.60%

Report Date

Aug 5, 2021

EPS Beat/Miss

-9.1%

Price Before

$59.37

Price After

$62.10

Q2 FY2021+0.47%

Report Date

May 5, 2021

EPS Beat/Miss

+8.3%

Price Before

$64.00

Price After

$64.30

Q1 FY2021-2.66%

Report Date

Feb 23, 2021

EPS Beat/Miss

-13.5%

Price Before

$78.65

Price After

$76.56

Q4 FY2020+0.90%

Report Date

Nov 9, 2020

EPS Beat/Miss

+9.6%

Price Before

$86.64

Price After

$87.42

Q3 FY2020+1.29%

Report Date

Aug 5, 2020

EPS Beat/Miss

+20.7%

Price Before

$63.61

Price After

$64.43

Q2 FY2020-0.26%

Report Date

May 7, 2020

EPS Beat/Miss

+12.3%

Price Before

$49.98

Price After

$49.85

Avg Beat Reaction+0.60%

Avg Miss Reaction+0.38%

Beat Rate4 / 8 quarters

Largest Move+4.60% (Q3 FY2021)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Arena Pharmaceuticals, Inc. (ARNA) most recently reported earnings on February 23, 2022 for Q1 FY2022, posting EPS of $-2.39 — missing the analyst consensus of $-2.26 by -5.8%. The next ARNA earnings date is expected around September 1, 2026.

Each quarter, investors track ARNA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ARNA revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

ARNA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

ARNA earnings · 5 questions

Arena Pharmaceuticals, Inc.'s next earnings report is expected around September 1, 2026. ARNA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ARNA historically reports after market close (AMC).

ARNA earnings datewhen is ARNA earningsARNA next earnings datewhen does ARNA report earningsARNA earnings calendar

▸ Source: FMP · Arena Pharmaceuticals, Inc. SEC filings · US GAAP · Arena Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026